WST

West Pharmaceutical Services
D

WST

Arincen83/100B
413.00
USD
1.73
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value379.45Plus+9%222Price 413.00531
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
OverviewFinancialsForecastEarningsDividendsCompany

West Pharmaceutical Services operating income 1985–2026

West Pharmaceutical Services's operating income in Q3 FY2026, the three months to 30 September 2026, was 267.40M USD, up 53.9% on the same quarter a year before. West Pharmaceutical Services's operating income over the last twelve months was 780.20M USD, up 23.7% on the twelve months before. In fiscal year 2025 it was 617.40M USD, up 3.8% on the year before.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

Operating income

Operating income · +17.3% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 2026780.20M+23.66%22.97%1.28B37.59%966.90M
FY202531 Dec 2025617.40M+3.83%20.09%1.10B35.89%770.60M
FY202431 Dec 2024594.60M-16.36%20.56%1.00B34.65%743.80M
FY202331 Dec 2023710.90M-6.89%24.09%1.13B38.38%844.10M
FY202231 Dec 2022763.50M+0.63%26.46%1.14B39.47%808.10M
FY202131 Dec 2021758.70M+81.07%26.80%1.17B41.45%879.70M
FY202031 Dec 2020419.00M+40.98%19.52%767.90M35.77%518.90M
FY201931 Dec 2019297.20M+16.64%16.12%608.80M33.02%403.20M
FY201831 Dec 2018254.80M+10.93%14.83%546.30M31.80%353.20M
FY201731 Dec 2017229.70M+6.59%14.35%514.80M32.17%326.20M
FY201631 Dec 2016215.50M+71.44%14.28%501.00M33.20%286.90M
FY201531 Dec 2015125.70M-30.90%8.99%454.10M32.48%217.70M
FY201431 Dec 2014181.90M+16.08%12.79%447.90M31.50%278.50M
FY201331 Dec 2013156.70M+14.80%11.45%429.50M31.39%252.20M
FY201231 Dec 2012136.50M+17.77%10.78%387.80M30.62%200.00M
FY201131 Dec 2011115.90M+9.34%9.72%339.00M28.43%183.40M
FY201031 Dec 2010106.00M0.00%9.60%317.60M28.75%161.30M
FY200931 Dec 2009106.00M-14.93%10.04%303.60M28.76%166.40M
FY200831 Dec 2008124.60M+10.27%11.85%302.60M28.79%186.10M
FY200731 Dec 2007113.00M+6.91%11.08%291.80M28.61%157.50M
FY200631 Dec 2006105.70M+44.40%11.57%261.80M28.67%149.90M
FY200531 Dec 200573.20M+14.55%10.46%193.80M27.70%122.90M
FY200431 Dec 200463.90M+17.25%11.80%167.50M30.93%94.50M
FY200331 Dec 200354.50M+104.12%11.11%155.80M31.75%84.80M
FY200231 Dec 200226.70M-35.35%6.36%117.60M28.02%82.80M
FY200131 Dec 200141.30M+15.69%10.41%116.10M29.25%74.70M
FY200031 Dec 200035.70M-46.23%8.30%140.40M32.64%75.90M
FY199931 Dec 199966.40M+2.63%14.15%180.00M38.37%102.10M
FY199831 Dec 199864.70M+4.52%14.39%167.50M37.25%97.00M
FY199731 Dec 199761.90M+16.14%13.68%164.00M36.24%93.80M
FY199631 Dec 199653.30M+10.35%11.62%156.80M34.18%84.00M
FY199531 Dec 199548.30M+2.55%11.70%147.80M35.80%77.90M
FY199431 Dec 199447.10M+14.60%12.90%139.20M38.13%70.20M
FY199331 Dec 199341.10M+3.53%11.79%126.60M36.31%63.10M
FY199231 Dec 199239.70M—11.74%120.40M35.60%63.30M
FY199131 Dec 1991-1.30M-106.13%-0.39%108.20M32.83%23.20M
FY199031 Dec 199021.20M-41.27%6.56%101.70M31.47%43.90M
FY198931 Dec 198936.10M+18.75%11.69%102.00M33.04%56.40M
FY198831 Dec 198830.40M+1.67%10.55%90.80M31.51%49.30M
FY198731 Dec 198729.90M-2.92%11.80%78.90M31.15%46.70M
FY198631 Dec 198630.80M+31.06%13.07%75.40M32.00%45.50M
FY198531 Dec 198523.50M—12.36%62.10M32.67%35.50M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about West Pharmaceutical Services's operating income

Source: Financial Modeling Prep